Biomedicine & Pharmacotherapy (Apr 2024)

Characterisation of new in vitro models and identification of potentially active drugs in angiosarcoma

  • Marta Mendiola,
  • Jani Saarela,
  • Francisco Javier Escudero,
  • Victoria Heredia-Soto,
  • Swapnil Potdar,
  • Silvia Rodriguez-Marrero,
  • Maria Miguel,
  • Jose Juan Pozo-Kreilinger,
  • Alberto Berjon,
  • Eduardo Ortiz-Cruz,
  • Jaime Feliu,
  • Andres Redondo

Journal volume & issue
Vol. 173
p. 116397

Abstract

Read online

Angiosarcoma is a rare soft tissue sarcoma originating from endothelial cells. Given that current treatments for advanced disease have shown limited efficacy, alternative therapies need to be identified. In rare diseases, patient-derived cell models are crucial for screening anti-tumour activity. In this study, cell line models were characterised in 2D and 3D cultures. The cell lines’ growth, migration and invasion capabilities were explored, confirming them as useful tools for preclinical angiosarcoma studies. By screening a drug library, we identified potentially effective compounds: 8-amino adenosine impacted cell growth and inhibited migration and invasion at considerably low concentrations as a single agent. No synergistic effect was detected when combining with paclitaxel, gemcitabine or doxorubicin. These results suggest that this compound could be a potentially useful drug in the treatment of AGS.

Keywords